West Paces Advisors’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21
Closed -$3.54K 651
2023
Q4
$3.54K Buy
+21
New +$3.06K ﹤0.01% 430
2022
Q3
Sell
-25
Closed -$3.03K 561
2022
Q2
$3.03K Hold
25
﹤0.01% 456
2022
Q1
$3.56K Hold
25
﹤0.01% 443
2021
Q4
$4.41K Buy
25
+3
+14% +$501 ﹤0.01% 440
2021
Q3
$3.4K Hold
22
﹤0.01% 456
2021
Q2
$2.96K Buy
+22
New +$2.96K ﹤0.01% 480

Other funds holding NOVT

West Paces Advisors's NOVT Position: Q1 2024 in Review

West Paces Advisors sold out of Novanta (NOVT) in Q1 2024, closing a stake of 21 shares — an estimated $3.54K sold.

West Paces Advisors first reported a position in NOVT in Q2 2021 and held it in 6 quarters. The position peaked at $4.41K in Q4 2021. 284 funds tracked by Wall St. Rank hold NOVT as of Q1 2024.

  • West Paces Advisors reported no remaining Novanta position as of Q1 2024 after selling out during the quarter.
  • West Paces Advisors sold 21 Novanta shares in Q1 2024, an estimated $3.54K.
  • West Paces Advisors first reported a position in Novanta in Q2 2021 and held it in 6 quarters.
  • West Paces Advisors's Novanta position peaked at $4.41K in Q4 2021.
  • 284 funds tracked by Wall St. Rank held Novanta as of Q1 2024.

Based on West Paces Advisors's 13F filing for Q1 2024, filed 15 Apr 2024.